Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03251469Phase 2Unknown
Phase 2, randomised, single-blind trial comparing Tranexamic Acid with Placebo (Saline) (2 arms). Primary endpoints: Number of transfusions of allogeneic RBC at 5 days and Total blood loss at 5 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03251469.